NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+2.82%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.45B
AUM Growth
+$1.45B
(-10%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
63.01%
Holding
41
New
5
Increased
1
Reduced
8
Closed
6
Top Buys
| 1 |
Edgewell Personal Care
EPC
|
$116M |
| 2 |
Viridian Therapeutics
VRDN
|
$19.3M |
| 3 |
ArriVent BioPharma
AVBP
|
$19.2M |
| 4 |
Metagenomi
MGX
|
$18.3M |
| 5 |
Kyverna Therapeutics
KYTX
|
$17.4M |
Top Sells
| 1 |
TSMC
TSM
|
$73.9M |
| 2 |
Edgewise Therapeutics
EWTX
|
$66.4M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$21.3M |
| 4 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$19.7M |
| 5 |
Salesforce
CRM
|
$15.2M |
Sector Composition
| 1 | Healthcare | 45.12% |
| 2 | Technology | 24.54% |
| 3 | Financials | 13.03% |
| 4 | Consumer Staples | 7.98% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Metagenomi
MGX
$65.3M
| $18.3M | 1.27% |
+1,739,175
| New | +$18.3M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.5B
| $17.7M | 1.22% |
118,383
| – | – |
|
|
28
Kyverna Therapeutics
KYTX
$160M
| $17.4M | 1.2% |
+700,000
| New | +$17.4M |
|
29
Inspire Medical Systems
INSP
$2.77B
| $14.1M | 0.97% |
65,524
| – | – |
|
30
IO Biotech
IOBT
$104M
| $8.8M | 0.61% |
5,088,258
-658,809
| -11% | -$1.14M |
|
31
AbCellera Biologics
ABCL
$1.25B
| $5.1M | 0.35% |
1,126,915
| – | – |
|
32
Treace Medical Concepts
TMCI
$464M
| $4.7M | 0.32% |
360,000
| – | – |
|
33
Marqeta
MQ
$2.85B
| $2.63M | 0.18% |
441,558
| – | – |
|
34
Galecto
GLTO
$4.21M
| $1.95M | 0.13% |
2,497,791
| – | – |
|
35
Spero Therapeutics
SPRO
$116M
| $807K | 0.06% |
468,902
| – | – |
|
|
36
Edgewise Therapeutics
EWTX
$1.51B
| – | – |
-6,071,703
| Closed | -$66.4M |
|
37
LAVA Therapeutics
LVTX
$41.3M
| – | – |
-1,878,194
| Closed | -$2.97M |
|
38
Rallybio
RLYB
$22.4M
| – | – |
-1,767,861
| Closed | -$4.23M |
|
|
39
TSMC
TSM
$1.2T
| – | – |
-710,780
| Closed | -$73.9M |
|
|
SPRB
40
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-6,722,336
| Closed | -$19.7M |
|
|
CBAY
41
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-900,000
| Closed | -$21.3M |
|